Make the right measurement: Discovery of an allosteric inhibition site for p300-HAT

por Gardberg, Anna S., Huhn, Annissa J., Cummings, Richard, Bommi-Reddy, Archana, Poy, Florence, Setser, Jeremy, Vivat, Valerie, Brucelle, Francois, Wilson, Jonathan
Publicado 2019

CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER+ breast cancer cells

por Bommi-Reddy, Archana, Park-Chouinard, Sungmi, Mayhew, David N., Terzo, Esteban, Hingway, Aparna, Steinbaugh, Michael J., Wilson, Jonathan E., Sims, Robert J., Conery, Andrew R.
Publicado 2022

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma

por Conery, Andrew R, Centore, Richard C, Neiss, Adrianne, Keller, Patricia J, Joshi, Shivangi, Spillane, Kerry L, Sandy, Peter, Hatton, Charlie, Pardo, Eneida, Zawadzke, Laura, Bommi-Reddy, Archana, Gascoigne, Karen E, Bryant, Barbara M, Mertz, Jennifer A, Sims, Robert J
Publicado 2016

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma

por Conery, Andrew R, Centore, Richard C, Neiss, Adrianne, Keller, Patricia J, Joshi, Shivangi, Spillane, Kerry L, Sandy, Peter, Hatton, Charlie, Pardo, Eneida, Zawadzke, Laura, Bommi-Reddy, Archana, Gascoigne, Karen E, Bryant, Barbara M, Mertz, Jennifer A, Sims, Robert J
Publicado 2016